GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gubra AS (OCSE:GUBRA) » Definitions » Accounts Receivable

Gubra AS (OCSE:GUBRA) Accounts Receivable : kr52.9 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Gubra AS Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Gubra AS's accounts receivables for the quarter that ended in Dec. 2023 was kr52.9 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Gubra AS's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 93.58.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Gubra AS's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was kr-3.23.


Gubra AS Accounts Receivable Historical Data

The historical data trend for Gubra AS's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gubra AS Accounts Receivable Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
43.50 41.27 83.98 36.09 52.91

Gubra AS Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Accounts Receivable Get a 7-Day Free Trial 83.98 - 36.09 24.39 52.91

Gubra AS Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Gubra AS Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Gubra AS's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=52.912/103.188*91
=93.58

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Gubra AS's accounts receivable are only considered to be worth 75% of book value:

Gubra AS's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(53.397+0.75 * 52.912+0.5 * 0-145.62
-0-0)/16.2904
=-3.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Gubra AS Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Gubra AS's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Gubra AS (OCSE:GUBRA) Business Description

Traded in Other Exchanges
Address
Hørsholm Kongevej 11B, Hørsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases.

Gubra AS (OCSE:GUBRA) Headlines

No Headlines